Heated Intravesical Chemotherapy: Biology and Clinical Utility.
Repository Usage Stats
Non-muscle-invasive bladder cancer can be a challenging disease to manage. In recent years, hyperthermia therapy in conjunction with intravesical therapy has been gaining traction as a treatment option for bladder cancer, especially if Bacillus Calmette-Guerin might not be available. Trials of intravesical chemotherapy with heat are few and there has been considerable heterogeneity between studies. However, multiple new trials have accrued and high-quality data are forthcoming. In this review, we discuss the role of combined intravesical hyperthermia and chemotherapy as a novel approach for the treatment of bladder cancer.
Published Version (Please cite this version)
Tan, Wei Phin, Thomas A Longo and Brant A Inman (2020). Heated Intravesical Chemotherapy: Biology and Clinical Utility. The Urologic clinics of North America, 47(1). pp. 55–72. 10.1016/j.ucl.2019.09.008 Retrieved from https://hdl.handle.net/10161/24272.
This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.
Clinical research interests:
Clinical trials of novel diagnostic tests and therapies for genitourinary malignancies, with a strong focus on bladder cancer.
Basic science research interests:
Immune therapies for cancer, hyperthermia and heat-based treatment of cancer, molecular biology of genitourinary cancers, novel diagnostics and therapies for genitourinary cancers
Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.